Biomedical literature and clinical narratives pose multifaceted challenges for natural language understanding, from precise entity extraction and document synthesis to multi-step diagnostic reasoning. This study extends a unified benchmark to evaluate GPT-5 and GPT-4o under zero-, one-, and five-shot prompting across five core biomedical NLP tasks: named entity recognition, relation extraction, multi-label document classification, summarization, and simplification, and nine expanded biomedical QA datasets covering factual knowledge, clinical reasoning, and multimodal visual understanding. Using standardized prompts, fixed decoding parameters, and consistent inference pipelines, we assessed model performance, latency, and token-normalized cost under official pricing. GPT-5 consistently outperformed GPT-4o, with the largest gains on reasoning-intensive datasets such as MedXpertQA and DiagnosisArena and stable improvements in multimodal QA. In core tasks, GPT-5 achieved better chemical NER and ChemProt scores but remained below domain-tuned baselines for disease NER and summarization. Despite producing longer outputs, GPT-5 showed comparable latency and 30 to 50 percent lower effective cost per correct prediction. Fine-grained analyses revealed improvements in diagnosis, treatment, and reasoning subtypes, whereas boundary-sensitive extraction and evidence-dense summarization remain challenging. Overall, GPT-5 approaches deployment-ready performance for biomedical QA while offering a favorable balance of accuracy, interpretability, and economic efficiency. The results support a tiered prompting strategy: direct prompting for large-scale or cost-sensitive applications, and chain-of-thought scaffolds for analytically complex or high-stakes scenarios, highlighting the continued need for hybrid solutions where precision and factual fidelity are critical.

Objective: Most existing fine-tuned biomedical large language models (LLMs) focus on enhancing performance in monolingual biomedical question answering and conversation tasks. To investigate the effectiveness of the fine-tuned LLMs on diverse biomedical NLP tasks in different languages, We present Taiyi, a bilingual fine-tuned LLM for diverse biomedical tasks. Materials and Methods: We first curated a comprehensive collection of 140 existing biomedical text mining datasets (102 English and 38 Chinese datasets) across over 10 task types. Subsequently, a two-stage strategy is proposed for supervised fine-tuning to optimize the model performance across varied tasks. Results: Experimental results on 13 test sets covering named entity recognition, relation extraction, text classification, question answering tasks demonstrate that Taiyi achieves superior performance compared to general LLMs. The case study involving additional biomedical NLP tasks further shows Taiyi's considerable potential for bilingual biomedical multi-tasking. Conclusion: Leveraging rich high-quality biomedical corpora and developing effective fine-tuning strategies can significantly improve the performance of LLMs within the biomedical domain. Taiyi shows the bilingual multi-tasking capability through supervised fine-tuning. However, those tasks such as information extraction that are not generation tasks in nature remain challenging for LLM-based generative approaches, and they still underperform the conventional discriminative approaches of smaller language models.

Deep neural language models have set new breakthroughs in many tasks of Natural Language Processing (NLP). Recent work has shown that deep transformer language models (pretrained on large amounts of texts) can achieve high levels of task-specific few-shot performance comparable to state-of-the-art models. However, the ability of these large language models in few-shot transfer learning has not yet been explored in the biomedical domain. We investigated the performance of two powerful transformer language models, i.e. GPT-3 and BioBERT, in few-shot settings on various biomedical NLP tasks. The experimental results showed that, to a great extent, both the models underperform a language model fine-tuned on the full training data. Although GPT-3 had already achieved near state-of-the-art results in few-shot knowledge transfer on open-domain NLP tasks, it could not perform as effectively as BioBERT, which is orders of magnitude smaller than GPT-3. Regarding that BioBERT was already pretrained on large biomedical text corpora, our study suggests that language models may largely benefit from in-domain pretraining in task-specific few-shot learning. However, in-domain pretraining seems not to be sufficient; novel pretraining and few-shot learning strategies are required in the biomedical NLP domain.

There is a broad range of BioNLP tasks for which active learning (AL) can significantly reduce annotation costs and a specific AL algorithm we have developed is particularly effective in reducing annotation costs for these tasks. We have previously developed an AL algorithm called ClosestInitPA that works best with tasks that have the following characteristics: redundancy in training material, burdensome annotation costs, Support Vector Machines (SVMs) work well for the task, and imbalanced datasets (i.e. when set up as a binary classification problem, one class is substantially rarer than the other). Many BioNLP tasks have these characteristics and thus our AL algorithm is a natural approach to apply to BioNLP tasks.